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Pseudomonas aeruginosaAbstract Pseudomonas aeruginosa isolates have acquired resistance to antibiotics
such as novel beta-lactams. The aim of this study was to investigate the blaPER-1,
blaVEB-1, and blaPSE-1 genes among isolates of P. aeruginosa among intensive care
unit (ICU) patients. Sixty-five isolates were collected. The antibiotic susceptibility
testing and combined disk tests were performed to detect the isolates producing
extended spectrum beta-lactamases (ESBLs) among ceftazidime-resistant isolates.
Polymerase chain reaction (PCR) amplification of blaPER-1, blaVEB-1, and blaPSE-1
genes was conducted. Ten (15.3%) isolates were ESBL-positive, of which 40%
(n = 4) belonged to males and 60% (n = 6) were collected from females. Moreover,
two and one isolates harbored blaPER-1 and blaVEB-1 genes, respectively.
 2016 Published by Elsevier Ltd. on behalf of Ministry of Health, Saudi Arabia. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Among several acquired beta-lactamase enzymes,
the blaPER-1 and blaVEB-1, although produced less
frequently, have clinical importance because of
conferring resistance to oxyimino beta-lactams
212 E. Davodian et al.[1]. Resistance to carbapenems is also of high con-
cern, because of the spectrum of activity against
Gram-negative and Gram-positive isolates. In Pseu-
domonas aeruginosa, similar to Klebsiella pneumo-
niae and Acinetobacter baumannii, a combination
of several mechanisms contributes to the high level
of resistance to carbapenems [2]. The aim of this
study was to detect the genes encoding Class A
extended spectrum beta-lactamases (ESBLs) of
blaPER-1, blaVEB-1, and blaPSE-1 among clinical isolates
of P. aeruginosa in intensive care unit (ICU) patients.
2. Material and methods
2.1. Antibiotic susceptibility and ESBL
testing
A total of 65 clinical isolates of P. aeruginosa were
collected from ICU patients and different infection
sites in hospitals in Tehran (n = 11), Shiraz (n = 12),
Kermanshah (n = 10), Ilam (n = 8), Kerman (n = 7),
and Ahvaz (n = 17) in Iran between 2009 and 2011.
The antibiotic susceptibility testing was con-
ducted according to Clinical and Laboratory Stan-
dards Institute 2012 guidelines. The antibiotics
disks were included as previously described. Briefly,
a swab of 0.5 McFarland was cultured on Mu¨eller–
Hinton agar and the disks were ordered following
the Kirby Bauer method [3]. The combined disk test
was performed with ceftazidime and cefotaxime
with or without clavulanic acid placed on Mu¨el-
ler–Hinton agar media (containing cloxacillin).
2.2. Polymerase chain reaction amplification
of blaPER-1, blaVEB-1, and blaPSE-1 genes
The polymerase chain reaction (PCR) was per-
formed for the amplification of blaPER-1, blaVEB-1,
and blaPSE-1 genes with specific primers.
The reaction mixture (PCR master mix)
included: 10 PCR buffer = 2.5 lL, MgCl2 (50 mM)Table 1 The prevalence of ESBL-positive isolates and
the presence of genes among several investigated
hospitals.
Hospital ESBL-positive blaPER-1 blaVEB-1
Tehran (n = 11) 4 0 0
Shiraz (n = 12) 3 0 0
Kermanshah (n = 10) 0 0 0
Ilam (n = 8) 0 0 0
Kerman (n = 7) 0 0 0
Ahvaz (n = 17) 3 2 1
Total 10 2 1
ESBL=.= 1.5 lL, di-nucleotide triphosphate (dNTP)
(10 Mm) = 0.75 lL, forward and reverse primers
(each with 100 lM) = 2.5 lL, Taq DNA polymerase
(5 U/lL) = 0.2 lL, template (DNA) = 1 lL, and
nuclease-free H2O = 14.05 lL (Sigma, Tehran pro-
vince, Tehran, Iran). The PCR amplification condi-
tions of the blaPER-1, blaVEB-1, and blaPSE-1 genes
are added in Table 1. The Tris-Acetate-EDTA
(TAE) buffer (EDTA 0.5 M, glacial acetic acid, and
Tris) was used for the electrophoresis of products.
The Student t test was used for analysis, and
p < 0.05 was considered as significant.
3. Results
Of 10 ESBL-positive ICU isolates, 20% (n = 2) har-
bored the blaPER-1 gene (925 bp), which occurred
in Ahwaz hospital in the South West of Iran. More-
over, one isolate amplified the blaVEB-1 (with
634 bp) in Ahwaz Hospital. The presence of two
blaPER-1 genes was demonstrated in two isolates
with panantibiotic resistance in urine samples.
4. Discussion
About half of the isolates in this study were resistant
to the third generation cephalosporins, but we
detected only 2 blaPER-1- and one blaVEB-1-positive
isolates, indicating that the presence of other
enzymes, such as Amp-C, ESBLs, and metallo-beta-
lactamases or mechanisms including efflux pumps
for cephalosporin resistance may be cooperated in
this phenomenon. Interestingly, although 44 iso-
lates were ceftazidime-resistant P. aeruginosa, 10
isolates were ESBL producers. Several previous stud-
ies obtained the same results. The presence of other
mechanisms of resistance or other enzymes is possi-
ble. This is the first report of these beta-lactamases
in the South West of Iran. The two blaPER-1- and one
blaVEB-1-positive isolates were collected from urine
samples in one hospital ICU setting of Ahvaz city
and also for two blaPER-1-positive isolates, the
antibiotic susceptibility profile was the same, sug-
gesting the occurrence of related isolates. Of the
10 ESBL-positive isolates, 40% (n = 4) belonged to
males and 60% (n = 6) were collected from female
patients. Furthermore, none of the ESBL producers
amplified the blaPSE-1 gene. The distribution of ESBL
producers and genes among several hospitals
of the country (Tehran, Shiraz, Kermanshah, Ilam,
Kerman, and Ahvaz) is demonstrated in Table 1.
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